CY1112730T1 - Συνθεση οκτενιδινης - Google Patents
Συνθεση οκτενιδινηςInfo
- Publication number
- CY1112730T1 CY1112730T1 CY20121100317T CY121100317T CY1112730T1 CY 1112730 T1 CY1112730 T1 CY 1112730T1 CY 20121100317 T CY20121100317 T CY 20121100317T CY 121100317 T CY121100317 T CY 121100317T CY 1112730 T1 CY1112730 T1 CY 1112730T1
- Authority
- CY
- Cyprus
- Prior art keywords
- octenidine
- optionally
- acetal
- groups
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Η εφεύρεση αφορά οκτενιδίνη ή ένα φαρμακευτικό άλας αυτής, ειδικότερα διυδροχλωρική οκτενιδίνη, η οποία προορίζεται για την από κοινού θεραπευτική χορήγηση της οκτενιδίνης εντός διαλύματος με μία πολυαλκοόλη του Τύπου 1: (Η-C-OH)a(HO-C-OH)b(H-CH)c, όπου a, b, c είναι ακέραιοι αριθμοί, όπου a+b είναι τουλάχιστον 2, κατά προτίμηση τουλάχιστον 3, το c επιλέγεται από 0, 1 ή έναν αριθμό από την περιοχή από 2 έως a+b, ενδεχομένως επιπροσθέτως με μία ή περισσότερες αλδεϋδομάδες, εφόσον αυτές σχηματίζουν (κυκλικές) ακετάλες με μία από τις υδροξυλικές ομάδες ή μία ή περισσότερες κετονοομάδες, ενδεχομένως ως ακετάλη με μία από τις υδροξυλικές ομάδες, ενδεχομένως επιπροσθέτως με μία ή περισσότερες καρβοξυλικές ομάδες, εφόσον η πολυαλκοόλη είναι μία κυκλική ακετάλη ή ακετάλη, κατά προτίμηση με μεγέθη δακτυλίου από 5 έως 7 άτομα ή αντίστοιχα ένα πολυμερές, έναν πολυαιθέρα ή έναν πολυεστέρα εξ αυτών με τον όρο ότι, εφόσον το a+b είναι 2 ή 3, η πολυαλκοόλη ευρίσκεται ως πολυμερές, πολυαιθέρας ή πολυεστέρας με τουλάχιστον δύο μονάδες του Τύπου 1, καθώς επίσης κιτ, τα οποία περιέχουν αυτές τις δραστικές ουσίες και τη χρήση αυτών για τη θεραπευτική αγωγή μολύνσεων και πληγών.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08450183A EP2201951A1 (de) | 2008-11-14 | 2008-11-14 | Octenidin-Zusammensetzung |
EP09756292A EP2291185B1 (de) | 2008-11-14 | 2009-11-13 | Octenidin-zusammensetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112730T1 true CY1112730T1 (el) | 2016-02-10 |
Family
ID=40383579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100317T CY1112730T1 (el) | 2008-11-14 | 2012-03-28 | Συνθεση οκτενιδινης |
Country Status (30)
Country | Link |
---|---|
US (2) | US8940324B2 (el) |
EP (2) | EP2201951A1 (el) |
JP (1) | JP5756018B2 (el) |
KR (1) | KR20110086718A (el) |
CN (1) | CN102209542A (el) |
AT (1) | ATE538788T1 (el) |
AU (1) | AU2009315654B2 (el) |
BR (1) | BRPI0915269A2 (el) |
CA (1) | CA2742921A1 (el) |
CO (1) | CO6331426A2 (el) |
CU (1) | CU20110105A7 (el) |
CY (1) | CY1112730T1 (el) |
DK (1) | DK2291185T3 (el) |
EA (1) | EA028177B1 (el) |
ES (1) | ES2381815T3 (el) |
GE (1) | GEP20135788B (el) |
HK (1) | HK1156838A1 (el) |
HR (1) | HRP20120277T1 (el) |
IL (1) | IL212596A (el) |
MX (1) | MX2011005092A (el) |
NZ (1) | NZ592775A (el) |
PE (1) | PE20110934A1 (el) |
PL (1) | PL2291185T3 (el) |
PT (1) | PT2291185E (el) |
RS (1) | RS52299B (el) |
SI (1) | SI2291185T1 (el) |
SM (1) | SMT201200028B (el) |
UA (1) | UA108190C2 (el) |
WO (1) | WO2010055122A1 (el) |
ZA (1) | ZA201103126B (el) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009049504A1 (de) * | 2009-10-15 | 2011-04-21 | Schülke & Mayr GmbH | Wund- und Schleimhautantiseptikum auf der Basis von Bispyridiniumalkanen |
DE102010025932A1 (de) | 2010-07-02 | 2012-01-05 | Schülke & Mayr GmbH | Antiseptikum auf der Basis von Bispyridiniumalkanen |
DE102010049113A1 (de) * | 2010-10-22 | 2012-04-26 | Schülke & Mayr GmbH | Mit einer antimikrobiellen Wirkstoffzubereitung getränktes textiles Flächengebilde mit einem Trägermaterial auf Basis von Polyolefin |
DE102012007212A1 (de) | 2012-04-11 | 2013-10-17 | Merz Pharma Gmbh & Co. Kgaa | Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff |
KR101718306B1 (ko) | 2015-07-27 | 2017-03-27 | 주식회사 퍼슨 | 옥테니딘염산염(Octenidine dihydrochloride)의 개선된 합성방법과 옥타니딘염산염을 포함하는 새로운 복합제의 제조방법 |
EA201890813A1 (ru) * | 2015-09-25 | 2018-09-28 | ФЛЕКСИГ ПАТЕНТ КОМПАНИ ЭлЭлСи | Новые композиции для защиты растений и их применение |
PL233480B1 (pl) * | 2017-09-28 | 2019-10-31 | Phytopharm Kleka Spolka Akcyjna | Koncentrat na bazie soli bis[4-(RHN)-1-pirydynio]alkanów w formie hydrożelu oraz sposób jego otrzymywania |
EP3771339A1 (en) * | 2019-07-29 | 2021-02-03 | The Procter & Gamble Company | Disinfectant composition |
CN113827565A (zh) * | 2020-06-16 | 2021-12-24 | 深圳长久康联生物科技有限公司 | 一种抗感染喷剂敷料及其制备方法、应用 |
CN113082029B (zh) * | 2021-03-02 | 2022-07-15 | 浙大宁波理工学院 | 一种伤口清洗消毒剂 |
CN117159784B (zh) * | 2023-03-31 | 2024-04-19 | 鹏拓生物科技(杭州)有限公司 | 用于难愈性创面修复的液体创可贴及其制备方法和应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4420484A (en) | 1979-08-13 | 1983-12-13 | Sterling Drug Inc. | Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof |
DK505588D0 (da) * | 1988-02-26 | 1988-09-09 | Jesper Hamburger | Middel og anvendelse af samme |
DE3925540C1 (el) | 1989-08-02 | 1990-08-30 | Schuelke & Mayr Gmbh, 2000 Norderstedt, De | |
CA2049728A1 (en) * | 1990-08-24 | 1992-02-25 | Kenji Kitamura | Washing composition capable of preventing and ameliorating skin irritation |
US5177065A (en) * | 1990-12-26 | 1993-01-05 | Silvetti Sr Anthony N | Monosaccharide containing wound healing preparation |
DE19647692C2 (de) * | 1996-11-05 | 2002-06-20 | Schuelke & Mayr Gmbh | Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion |
DE19647892A1 (de) | 1996-11-20 | 1998-06-04 | Forschungszentrum Juelich Gmbh | Verfahren zur katalytischen, enantioselektiven Reduktion von Ketonen |
AUPO690997A0 (en) * | 1997-05-20 | 1997-06-12 | Novapharm Research (Australia) Pty Ltd | Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism |
DE10109925B4 (de) | 2001-03-01 | 2004-11-25 | Antiseptica Chemisch-Pharmazeutische Produkte Gmbh | Wund- und Schleimhautantiseptikum |
DE10205883A1 (de) * | 2002-02-13 | 2003-08-21 | Schuelke & Mayr Gmbh | Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen |
DE10212321A1 (de) | 2002-03-20 | 2003-10-09 | Sanguibio Tech Ag | Verwendung eines oder mehrerer von Plasma und Zellwandbestandteilen befreiten natürlichen oder modifizierten Sauerstoffbinder zur externen Behandlung offener, insbesondere chronischer Wunden |
US8198326B2 (en) * | 2004-09-07 | 2012-06-12 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
DE102004052308B4 (de) * | 2004-10-12 | 2013-04-04 | Divapharma-Knufinke Arzneimittelwerk Gmbh | Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums |
DE102005002645A1 (de) | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Alkoholische Zusammensetzungen für die Desinfektion |
DE102005002644A1 (de) | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung |
DE102005058978A1 (de) | 2005-08-26 | 2007-03-29 | Bode Chemie Gmbh & Co. Kg | Wund- und Schleimhautdesinfektionsmittel |
DE102005063375A1 (de) | 2005-09-15 | 2007-04-19 | Schülke & Mayr GmbH | Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen |
DE102005045145A1 (de) | 2005-09-15 | 2007-03-29 | Schülke & Mayr GmbH | Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen |
FR2907683A1 (fr) | 2006-10-27 | 2008-05-02 | De Potter Philippe Viseux | Composition medicale pour cicatrisation des plaies et pansements permettant son application |
US9555167B2 (en) | 2006-12-11 | 2017-01-31 | 3M Innovative Properties Company | Biocompatible antimicrobial compositions |
US20080175801A1 (en) * | 2007-01-18 | 2008-07-24 | The Procter & Gamble Company | Stable peroxide containing personal care compositions |
-
2008
- 2008-11-14 EP EP08450183A patent/EP2201951A1/de not_active Withdrawn
-
2009
- 2009-11-13 JP JP2011536025A patent/JP5756018B2/ja not_active Expired - Fee Related
- 2009-11-13 SI SI200930217T patent/SI2291185T1/sl unknown
- 2009-11-13 KR KR20117012507A patent/KR20110086718A/ko not_active Application Discontinuation
- 2009-11-13 UA UAA201107410A patent/UA108190C2/ru unknown
- 2009-11-13 US US13/128,266 patent/US8940324B2/en not_active Expired - Fee Related
- 2009-11-13 DK DK09756292T patent/DK2291185T3/da active
- 2009-11-13 RS RSP20120133 patent/RS52299B/en unknown
- 2009-11-13 PT PT09756292T patent/PT2291185E/pt unknown
- 2009-11-13 BR BRPI0915269A patent/BRPI0915269A2/pt not_active IP Right Cessation
- 2009-11-13 AU AU2009315654A patent/AU2009315654B2/en not_active Ceased
- 2009-11-13 CA CA2742921A patent/CA2742921A1/en not_active Abandoned
- 2009-11-13 GE GEAP2009012244 patent/GEP20135788B/en unknown
- 2009-11-13 CN CN2009801448968A patent/CN102209542A/zh active Pending
- 2009-11-13 MX MX2011005092A patent/MX2011005092A/es active IP Right Grant
- 2009-11-13 EP EP09756292A patent/EP2291185B1/de not_active Revoked
- 2009-11-13 NZ NZ59277509A patent/NZ592775A/en not_active IP Right Cessation
- 2009-11-13 PE PE2011001041A patent/PE20110934A1/es not_active Application Discontinuation
- 2009-11-13 EA EA201100762A patent/EA028177B1/ru not_active IP Right Cessation
- 2009-11-13 WO PCT/EP2009/065111 patent/WO2010055122A1/de active Application Filing
- 2009-11-13 PL PL09756292T patent/PL2291185T3/pl unknown
- 2009-11-13 ES ES09756292T patent/ES2381815T3/es active Active
- 2009-11-13 AT AT09756292T patent/ATE538788T1/de active
-
2011
- 2011-04-28 ZA ZA2011/03126A patent/ZA201103126B/en unknown
- 2011-05-01 IL IL212596A patent/IL212596A/en not_active IP Right Cessation
- 2011-05-13 CU CU20110105A patent/CU20110105A7/es unknown
- 2011-05-25 CO CO11064767A patent/CO6331426A2/es not_active Application Discontinuation
- 2011-07-25 HK HK11107685A patent/HK1156838A1/xx not_active IP Right Cessation
-
2012
- 2012-03-28 HR HRP20120277AT patent/HRP20120277T1/hr unknown
- 2012-03-28 CY CY20121100317T patent/CY1112730T1/el unknown
- 2012-06-11 SM SM201200028T patent/SMT201200028B/it unknown
-
2014
- 2014-10-30 US US14/528,869 patent/US20150126557A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112730T1 (el) | Συνθεση οκτενιδινης | |
AR091604A1 (es) | Potenciacion de autofagia o aumento de longevidad por administracion de urolitinas o precursores de las mismas, compuesto | |
MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
MA32394B1 (fr) | Composes pegyles d'insuline lispro | |
MX2009008439A (es) | Nuevos inhibidores de la replicacion del virus de hepatitis c. | |
BRPI0810064B8 (pt) | compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos | |
MX358491B (es) | Una composicion farmacéutica para tratar cáncer, que comprende un conjugado de interferón alfa. | |
MX2012003171A (es) | Novedosos inhibidores macrociclicos de la replicacion del virus de hepatitis c. | |
NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
WO2013117770A3 (en) | Cosmetic treatment method, and composition comprising a glyoxylic acid ester | |
BR112014002672A2 (pt) | composições compreendendo monoésteres de isossorbida e dióis vicinais alifáticos | |
CY1120050T1 (el) | Φαρμακοτεχνικες μορφες για την αποδεσμευση δραστικων ενωσεων | |
BR112012006070A2 (pt) | composições e métodos para tratar distúrbios convulsivos. | |
UY32644A (es) | Compuesto anticancerígeno y composición farmacéutica que lo contiene | |
US20220008364A1 (en) | Macrocyclic compounds and uses thereof | |
NZ621994A (en) | Transdermal venous access locking solutions | |
AR072066A1 (es) | Uso de composicion que comprende oligosacaridos no digeribles | |
GT200900295A (es) | Composición farmacéutica que comprende la combinación del agente antimicrobiano ciprofloxacino y el agente antioxidante ácido ascórbico para el tratamiento de infecciones urinarias. | |
TH118942A (th) | สูตรผสมที่ปลดปล่อยเป็นเวลานาน | |
NZ717866A (en) | Compositions and methods for treating bacterial infections using ceftaroline | |
TH125821B (th) | องค์ประกอบและวิธีการสำหรับการบำบัดการติดเชื้อแบคที่เรียโดยใช้เซฟทาโรลีน | |
UA101501C2 (ru) | Средство для лечения заболеваний, вызванных патогенными микроорганизмами и воспалительными процессами, рогальских | |
TH156760A (th) | อนุพันธ์ของแซงไลเฟห์รินและวิธีสำหรับการผลิตของมัน | |
WO2012106722A3 (en) | Treatment of bacterial infections |